New program aims to ease sexual and urinary woes for prostate cancer survivors
NCT ID NCT06637852
First seen Jun 26, 2026 · Last updated Jul 31, 2026 · Updated 2 times
Summary
This study tests a program called SUFICS-PACT for prostate cancer survivors who have sexual or urinary problems after treatment. The program includes screening, counseling from mental health professionals, and close follow-up. About 200 participants will be randomly assigned to receive the program or usual care. The goal is to see if this approach helps more people get treated and feel better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SUFICS-PACT collaborative care program (behavioral intervention with screening, counseling, and care management)
- What this could lead to
- If successful, this program could provide a practical way to help prostate cancer survivors manage sexual and urinary problems, improving their quality of life.
- What could go wrong
- This is a relatively small, early-stage trial at one hospital, so results may not apply broadly. The program is behavioral, so benefits may vary and it won't cure the underlying issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NYU Langone Health
New York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- A tiny drop of blood might be enough: study tests fingerstick accuracy
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks